Feasibility, Safety, Efficacy And Immunologic Impact Of Daily Ultra-Low-Dose Interleukin-2 For Steroid-Refractory Chronic Graft-Versus-Host Disease: A Phase I Study

✍ Scribed by J. Koreth; K.E. Stevenson; H.T. Kim; S. McDonough; V.T. Ho; E.P. Alyea; C. Cutler; P. Armand; J.H. Antin; J. Ritz; R.J. Soiffer

• Book ID: 116281282
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 64 KB
• Volume: 16
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2009.12.055